300 related articles for article (PubMed ID: 17763870)
21. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.
Zhai L; Chen M; Blom J; Theander TG; Christensen SB; Kharazmi A
J Antimicrob Chemother; 1999 Jun; 43(6):793-803. PubMed ID: 10404318
[TBL] [Abstract][Full Text] [Related]
22. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
[TBL] [Abstract][Full Text] [Related]
23. Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major.
Keighobadi M; Emami S; Fakhar M; Shokri A; Mirzaei H; Hosseini Teshnizi S
Parasitol Int; 2019 Apr; 69():103-109. PubMed ID: 30582997
[TBL] [Abstract][Full Text] [Related]
24. TTAS a new stilbene derivative that induces apoptosis in Leishmania infantum.
Tolomeo M; Roberti M; Scapozza L; Tarantelli C; Giacomini E; Titone L; Saporito L; Di Carlo P; Colomba C
Exp Parasitol; 2013 Jan; 133(1):37-43. PubMed ID: 23103597
[TBL] [Abstract][Full Text] [Related]
25. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
Chen M; Christensen SB; Blom J; Lemmich E; Nadelmann L; Fich K; Theander TG; Kharazmi A
Antimicrob Agents Chemother; 1993 Dec; 37(12):2550-6. PubMed ID: 8109916
[TBL] [Abstract][Full Text] [Related]
26. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI
Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389
[TBL] [Abstract][Full Text] [Related]
27. Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.
Ponte-Sucre A; Faber JH; Gulder T; Kajahn I; Pedersen SE; Schultheis M; Bringmann G; Moll H
Antimicrob Agents Chemother; 2007 Jan; 51(1):188-94. PubMed ID: 17088484
[TBL] [Abstract][Full Text] [Related]
28. Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.
Schad C; Baum U; Frank B; Dietzel U; Mattern F; Gomes C; Ponte-Sucre A; Moll H; Schurigt U; Schirmeister T
Antimicrob Agents Chemother; 2016 Feb; 60(2):797-805. PubMed ID: 26596939
[TBL] [Abstract][Full Text] [Related]
29. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR
J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790
[TBL] [Abstract][Full Text] [Related]
30. The sesquiterpene (-)-α-bisabolol is active against the causative agents of Old World cutaneous leishmaniasis through the induction of mitochondrial-dependent apoptosis.
Corpas-López V; Merino-Espinosa G; Díaz-Sáez V; Morillas-Márquez F; Navarro-Moll MC; Martín-Sánchez J
Apoptosis; 2016 Oct; 21(10):1071-81. PubMed ID: 27539477
[TBL] [Abstract][Full Text] [Related]
31. In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major.
Shokri A; Emami S; Fakhar M; Teshnizi SH; Keighobadi M
Acta Trop; 2017 Mar; 167():73-78. PubMed ID: 28017860
[TBL] [Abstract][Full Text] [Related]
32. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
Rodrigues KA; Dias CN; Néris PL; Rocha Jda C; Scotti MT; Scotti L; Mascarenhas SR; Veras RC; de Medeiros IA; Keesen Tde S; de Oliveira TB; de Lima Mdo C; Balliano TL; de Aquino TM; de Moura RO; Mendonça Junior FJ; de Oliveira MR
Eur J Med Chem; 2015 Dec; 106():1-14. PubMed ID: 26513640
[TBL] [Abstract][Full Text] [Related]
33. In-vitro and in-vivo comparative effects of the spring and autumn-harvested Artemisia aucheri Bioss extracts on Leishmania major.
KarimiPourSaryazdi A; Ghaffarifar F; Dalimi A; Dayer MS
J Ethnopharmacol; 2020 Jul; 257():112910. PubMed ID: 32344159
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007).
Khan MA; Maruno M; Khaskhely NM; Ramzi ST; Hosokawa A; Uezato H; Landires EA; Hashiguchi Y; Nonaka S
Am J Trop Med Hyg; 2002 Aug; 67(2):184-90. PubMed ID: 12389945
[TBL] [Abstract][Full Text] [Related]
35. Insights about resveratrol analogs against trypanothione reductase of
da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
[TBL] [Abstract][Full Text] [Related]
36. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations.
Abamor ES; Allahverdiyev AM
Exp Parasitol; 2016 Jul; 166():150-63. PubMed ID: 27109311
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of chalcone analogues with increased antileishmanial activity.
Boeck P; Bandeira Falcão CA; Leal PC; Yunes RA; Filho VC; Torres-Santos EC; Rossi-Bergmann B
Bioorg Med Chem; 2006 Mar; 14(5):1538-45. PubMed ID: 16386424
[TBL] [Abstract][Full Text] [Related]
39. Antileishmanial Activity of Date (Phoenix dactylifera L) Fruit and Pit Extracts In Vitro.
Albakhit S; Khademvatan S; Doudi M; Foroutan-Rad M
J Evid Based Complementary Altern Med; 2016 Oct; 21(4):NP98-NP102. PubMed ID: 27242378
[TBL] [Abstract][Full Text] [Related]
40. In Vitro Determination of Antileshmanial Activities of Benzimidazolium Derivatives on L. major Promastigotes and Amastigotes.
Kelleci K; Gölebatmaz E
Acta Parasitol; 2023 Mar; 68(1):51-55. PubMed ID: 36348181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
